MAGNESIUM TRISILICATE

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
261.0 -7.0 0 8 145.0 4 0.0
UNII
C2E1CI501T
CAS
39365-87-2
SYNONYMS
  • Magnesium Trisilicate
  • Magnesium Silicate Hydrate (mg(sub 2)si(sub 3)o(sub 8).xh2o)
  • Trimax
  • Magnesium Trisilicate [ep]
  • Magnesium Trisilicate [usp]
  • Foamcoat Component Magnesium Trisilicate
  • Magnesium Trisilicate Component Of Foamcoat
  • Foamicon Component Magnesium Trisilicate
  • Magnesium Trisilicate Component Of Foamicon
  • Gaviscon Component Magnesium Trisilicate
  • Magnesium Trisilicate Component Of Gaviscon
  • Magnesium Trisilicate [orange Book]
  • Magnesium Trisilicate [mart.]
  • Magnesium Trisilicate [inci]
  • Magnesium Trisilicate [ii]
  • Magnesium Trisilicate [vandf]
ZINC ID(s)
Availability
Present in 0 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

(Browse) Purchasable Analogs in ZINC

Dosages

Route Formulation Per Unit Dose
Oral Powder, For Oral Suspension 2.4%
Oral Tablet 76.89MG
Oral Tablet (immed./comp. Release), Uncoated, Chewable 76.89MG
Oral Tablet, Coated 20MG
Oral Tablet, Delayed Action 26.4MG

More Information

Usage Over Time

Comments